Literature DB >> 16945455

Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.

Tetsuo Nakayama1, Kazumasa Onoda.   

Abstract

General physicians, pediatricians and parents realize that serious adverse events occur with an extremely rare incidence, but have no information on the incidences of vaccine-associated adverse events. A proper understanding of vaccine adverse events would be helpful in promoting an immunization strategy. Causal association can rarely be determined in adverse events through laboratory examinations. We examined the cases reported in the post-marketing surveillance of the Kitasato Institute, categorizing them into two groups: allergic reactions and severe systemic illnesses. Anaphylactic patients with gelatin allergy after immunization with live measles, rubella and mumps monovalent vaccines have been reported since 1993, but the number of reported cases with anaphylaxis dramatically decreased after 1999 when gelatin was removed from all brands of DPT. The incidence of anaphylactic reaction was estimated to be 0.63 per million for Japanese encephalitis virus (JEV) vaccine, 0.95 for DPT and 0.68 for Influenza vaccine, but the causative component has not yet been specified. Among 67.2 million immunization practices, 6 cases with encephalitis or encephalopathy, 7 with acute disseminated encephalomyelitis (ADEM), 10 with Guillain-Barré syndrome and 12 with idiopathic thrombocytopenic purpura (ITP) were reported. The wild-type measles virus genome was detected in a patient with encephalitis and in two of four bone marrow aspirates obtained from ITP after measles vaccination. Enterovirus infection was identified in two patients after mumps vaccination (one each with encephalitis and ADEM), one patient with encephalitis after immunization with JEV vaccine, and one with aseptic meningitis after immunization with influenza vaccine. The total estimated incidence of serious neurological illness after vaccination was 0.1-0.2 per million immunization practices. We found that enterovirus or wild-type measles virus infection was coincidentally associated with vaccination in several cases suspected of being vaccine adverse events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945455     DOI: 10.1016/j.vaccine.2006.05.130

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.

Authors:  Shigefumi Okamoto; Hironori Yoshii; Masaaki Matsuura; Asato Kojima; Toyokazu Ishikawa; Takami Akagi; Mitsuru Akashi; Michiaki Takahashi; Koichi Yamanishi; Yasuko Mori
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

2.  Transmission of seasonal outbreak of childhood enteroviral aseptic meningitis and hand-foot-mouth disease.

Authors:  Sue K Park; Boyoung Park; Moran Ki; Ho Kim; Kwan Lee; Cheoll Jung; Young Mo Sohn; Sung-Min Choi; Doo-Kwun Kim; Dong Seok Lee; Joon Tae Ko; Moon Kyu Kim; Hae-Kwan Cheong
Journal:  J Korean Med Sci       Date:  2010-04-21       Impact factor: 2.153

3.  Anaphylaxis following quadrivalent human papillomavirus vaccination.

Authors:  Julia M L Brotherton; Mike S Gold; Andrew S Kemp; Peter B McIntyre; Margaret A Burgess; Sue Campbell-Lloyd
Journal:  CMAJ       Date:  2008-09-01       Impact factor: 8.262

Review 4.  [Immunization in children and adolescents with rheumatic diseases].

Authors:  K Minden; M Niewerth; M Borte; W Singendonk; J-P Haas
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

5.  Acute disseminated encephalomyelitis and routine childhood vaccinations - a self-controlled case series.

Authors:  T J Martin; M Fahey; M Easton; H J Clothier; R Samuel; N W Crawford; J P Buttery
Journal:  Hum Vaccin Immunother       Date:  2021-04-09       Impact factor: 3.452

6.  Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine.

Authors:  Cristiano Alicino; Maria Teresa Infante; Ilaria Gandoglia; Nadia Miolo; Gian Luigi Mancardi; Simona Zappettini; Elisabetta Capello; Andrea Orsi; Tiziano Tamburini; Marina Grandis
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  A 44-year-old patient with a new-onset seizure disorder after vaccination against Japanese encephalitis: a case report.

Authors:  Christoph Schulze
Journal:  J Med Case Rep       Date:  2013-03-12

8.  The Saudi Thoracic Society guidelines for influenza vaccinations.

Authors:  Mohammed O Zeitouni; Ali M Al Barrak; Mohamed S Al-Moamary; Nasser S Alharbi; Majdy M Idrees; Abdullah A Al Shimemeri; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

9.  Immunologic factors may play a role in herpes simplex virus 1 reactivation in the brain and retina after influenza vaccination.

Authors:  Lynn M Hassman; David A DiLoreto
Journal:  IDCases       Date:  2016-09-22

10.  Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases.

Authors:  Jiangan Xie; Lili Zhao; Shangbo Zhou; Yongqun He
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.